{"id":195106,"date":"2026-08-11T09:18:36","date_gmt":"2026-08-11T03:48:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=195106"},"modified":"2026-08-11T09:18:36","modified_gmt":"2026-08-11T03:48:36","slug":"kwality-pharmaceuticals-ltd-share-price-52-week-high-2026-08-11","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/kwality-pharmaceuticals-ltd-share-price-52-week-high-2026-08-11\/","title":{"rendered":"Kwality Pharmaceuticals Ltd. (KPL) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\">Kwality Pharmaceuticals Ltd.<\/a> rose 8.44% to Rs 3,395.20, hit a fresh 52-week high of Rs 3,444.60 and carried a market capitalisation of Rs 2,707.20 crore.<\/p>\n<p style=\"margin-top:0!important;\">Kwality Pharmaceuticals Ltd. Share Price moved into focus on 11 August 2026 after the stock climbed to Rs 3,395.20, up Rs 264.35 or 8.44% from the previous close of Rs 3,130.85, and registered a fresh 52-week high of Rs 3,444.60. The company\u2019s market capitalisation stood at Rs 2,707.20 crore, putting it near the upper end of the supplied Pharmaceuticals &amp; Drugs peer set by size.<\/p>\n<p>For investors searching for Kwality Pharmaceuticals Ltd. Share Price Today, the key takeaway is straightforward: the verified data confirms a strong intraday move, a new one-year high and active participation with turnover of Rs 2.13 crore on volume of 6,286 shares. The supplied data confirms the price event, but it does not establish a company-specific catalyst for why the stock is moving today.<\/p>\n<p>That still makes the stock relevant in Stock Market Today and Share Market Today screens. A fresh 52-week high often attracts attention because it signals renewed price discovery, invites Momentum Analysis and pushes the stock into Market News conversations. Univest notes that this move now deserves a closer look through price action, valuation, profitability, sector positioning and peer comparison rather than through speculation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Kwality Pharmaceuticals Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,395.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,130.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 264.35 (+8.44%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,309.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,444.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,219.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6,286<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.13 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,707.2 crore<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) traded at Rs 3,395.2. versus the previous close of Rs 3,130.85, a rise of 8.44%. The stock opened at Rs 3,309.4, reached Rs 3,444.6, touched Rs 3,219.45. Reported volume was 6,286.<\/p>\n<p>Kwality Pharmaceuticals Ltd. Share Price Today reflects a sharp positive session, with the stock opening at Rs 3,309.40, moving between a day low of Rs 3,219.45 and a day high of Rs 3,444.60, and holding at Rs 3,395.20 at the time of the captured data. That sequence confirms both intraday strength and a fresh yearly high.<\/p>\n<p>From the previous close of Rs 3,130.85, the stock added Rs 264.35. In percentage terms, that was an 8.44% rise, enough to place Kwality Pharmaceuticals Ltd. Share Price among the more closely watched Market Movers and 52 Week High Stocks within the Indian Stock Market session. The fact that the day\u2019s high itself became the new 52-week peak shows that the breakout attempt was not marginal.<\/p>\n<p>The stock opened at Rs 3,309.40, already above the previous close, which pointed to a firm start. It then traded as high as Rs 3,444.60 before easing slightly, while still remaining well above both the opening level and the previous close. That kind of intraday range often draws attention from traders tracking Price Action and Share Price Update screens on NSE News and BSE News platforms.<\/p>\n<p>Turnover stood at Rs 2.13 crore and current volume was 6,286 shares. On its own, that confirms active trading interest during the session, although the supplied data does not include average volume or delivery participation for a deeper Volume Analysis. From a Univest perspective, the immediate question after this price move is whether the valuation and profitability profile support the added attention around Kwality Pharmaceuticals Ltd. Stock News.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_Ltd_KPL_Fundamental_Analysis\"><\/span><strong>Kwality Pharmaceuticals Ltd. (KPL) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,707.2 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 78.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 318.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. was valued at a P\/E ratio of 40.09x, a P\/B ratio of 9.77x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<p>Per-share and shareholder-return metrics included EPS of Rs 78.1, book value per share of Rs 318.8, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.46x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">52.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,396.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.78x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.96%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,707.2 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 146.63 crore<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Kwality Pharmaceuticals Ltd. (KPL) has a P\/E ratio of 40.09x, which is above the benchmark median of 18.46x, a difference of +117.17%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Kwality Pharmaceuticals Ltd. (KPL) has a ROE of 28.21%, which is above the benchmark median of 10.21%, a difference of +176.3%. Kwality Pharmaceuticals Ltd. (KPL) has a ROCE of 26.35%, which is above the benchmark median of 12.96%, a difference of +103.32%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,631.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">66.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,513.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">181.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/nglfine\/ngl-fine-chem-ltd-share-price-today\"><strong>NGL Fine-Chem Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NGLFINE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,118.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.91<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/venusrem\/venus-remedies-ltd-share-price-today\"><strong>Venus Remedies Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">VENUSREM-BE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,068.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.89<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hesterbio\/hester-biosciences-ltd-share-price-today\"><strong>Hester Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HESTERBIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,057.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.63<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.12<\/td>\n<\/tr>\n<\/table>\n<p>Kwality Pharmaceuticals Ltd. (KPL) has a P\/E ratio of 40.09x compared with the displayed peer median of 44.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 16.17% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 14.12%, providing a capital-efficiency comparison. Kwality Pharmaceuticals Ltd. (KPL) has a market capitalisation of Rs 2,707.2 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Kwality_Pharmaceuticals_Ltd\"><\/span><strong>Why Investors Are Watching Kwality Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Kwality Pharmaceuticals Ltd. Share Price is attracting attention because a fresh 52-week peak combines with a notable profitability profile and above-average industry scale.<\/p>\n<ul>\n<li><strong>Price action:<\/strong> the stock rose 8.44% to Rs 3,395.20 and touched a fresh 52-week high of Rs 3,444.60.<\/li>\n<li><strong>Intraday range:<\/strong> it opened at Rs 3,309.40, slipped to Rs 3,219.45, and still held well above the previous close of Rs 3,130.85.<\/li>\n<li><strong>Trading activity:<\/strong> turnover was Rs 2.13 crore on volume of 6,286 shares, keeping the move relevant in daily Stock Updates.<\/li>\n<li><strong>Profitability context:<\/strong> ROE of 28.21% and ROCE of 26.35% are both above the same-industry median.<\/li>\n<li><strong>Valuation context:<\/strong> P\/E of 40.09 is above the industry median of 18.46, while P\/B of 9.77 is well above the median of 1.78.<\/li>\n<li><strong>Industry scale:<\/strong> market cap of Rs 2,707.20 crore is above both the same-industry median and average within the 136-company benchmark.<\/li>\n<li><strong>Momentum watchpoint:<\/strong> the supplied 14-day RSI is 46.66, which sits in a broadly neutral zone even after the sharp session move.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Kwality_Pharmaceuticals_Ltd\"><\/span><strong>About Kwality Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Kwality Pharmaceuticals Ltd. operates in the Healthcare sector and is classified under the Pharmaceuticals &amp; Drugs industry. Based on the supplied company context, the stock sits within a segment of the Indian stock market where investors usually track valuation multiples, return ratios and relative scale very closely because peer comparisons are often meaningful.<\/p>\n<p>In the current market context, Kwality Pharmaceuticals Ltd. is being assessed alongside other listed pharmaceutical companies on measures such as P\/E, P\/B, ROE, ROCE and market capitalisation. With a market cap of Rs 2,707.20 crore, the company is larger than the median and average company in the supplied same-industry benchmark. That scale, combined with a fresh one-year high in the share price, has brought the company into sharper focus in Kwality Pharmaceuticals Ltd. Latest News and Kwality Pharmaceuticals Ltd. Company News searches.<\/p>\n<p>For investors doing basic company-level work, the present data set supports a view of Kwality as a listed pharmaceuticals company whose current market attention is being driven by stock performance, profitability ratios and sector-relative valuation rather than by any verified company-specific announcement in the supplied feed.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Kwality_Pharmaceuticals_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Kwality Pharmaceuticals Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\">Kwality Pharmaceuticals Ltd. (KPL) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors tracking Kwality Pharmaceuticals Ltd. Share Price can use Univest to follow live Share Price moves, 52-week levels, valuation ratios, peer positioning, sector context and broader stock analysis in one place. That is especially useful on days when a stock enters a fresh 52-week high screen and interest rises quickly.<\/p>\n<p>Univest also helps users monitor metrics such as market capitalisation, P\/E ratio, P\/B ratio, ROE, ROCE, EPS, book value and dividend yield alongside price action. For readers following Kwality Pharmaceuticals Ltd. Share Price Today, Kwality Pharmaceuticals Ltd. Share Price Live and Kwality Pharmaceuticals Ltd. Shareholding Pattern trends, keeping the stock on a structured watchlist can make day-to-day market tracking more efficient.<\/p>\n<p>As always, Univest frames these metrics as decision-support information rather than a recommendation. After a strong move to a yearly high, the next practical step is to monitor whether price strength, valuation and sector-relative profitability continue to align.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_Kwality_Pharmaceuticals_Ltd_Share_Price_Today\"><\/span><strong>What is the latest Kwality Pharmaceuticals Ltd. Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals Ltd. Share Price Today was Rs 3,395.20 in the supplied data snapshot. The stock was up Rs 264.35, or 8.44%, from the previous close of Rs 3,130.85 during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Kwality_Pharmaceuticals_Ltd_hit_a_52-week_high_today\"><\/span><strong>Did Kwality Pharmaceuticals Ltd. hit a 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, Kwality Pharmaceuticals Ltd. hit a fresh 52-week high of Rs 3,444.60. The stock later traded at Rs 3,395.20, which still kept it firmly above the previous close and in focus on yearly-high screens.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Kwality_Pharmaceuticals_Ltd_rise_today\"><\/span><strong>How much did Kwality Pharmaceuticals Ltd. rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock rose by Rs 264.35 on the day, which translated into an 8.44% gain over the previous close of Rs 3,130.85. That sharp move helped push Kwality Pharmaceuticals Ltd. to a fresh one-year high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_intraday_trading_range_for_Kwality_Pharmaceuticals_Ltd\"><\/span><strong>What was the intraday trading range for Kwality Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals Ltd. opened at Rs 3,309.40, touched a day low of Rs 3,219.45 and a day high of Rs 3,444.60. The session range confirms strong intraday volatility alongside the fresh 52-week peak.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Kwality_Pharmaceuticals_Ltd\"><\/span><strong>What is the market capitalisation of Kwality Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied market capitalisation for Kwality Pharmaceuticals Ltd. was Rs 2,707.20 crore. That is above the same-industry median of Rs 146.63 crore and the average of Rs 483.79 crore in the benchmark set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Kwality_Pharmaceuticals_Ltd_expensive_on_PE_compared_with_its_industry\"><\/span><strong>Is Kwality Pharmaceuticals Ltd. expensive on P\/E compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals Ltd. trades at a P\/E of 40.09. That is above the same-industry median of 18.46 but below the industry average of 52.67, so the stock screens richer than the midpoint of the benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Kwality_Pharmaceuticals_Ltd_compare_on_PB_ratio\"><\/span><strong>How does Kwality Pharmaceuticals Ltd. compare on P\/B ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s P\/B ratio is 9.77, compared with a same-industry median of 1.78 and average of 2.42. This places Kwality Pharmaceuticals Ltd. at a clear premium on book-value valuation within the supplied industry set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_ROE_and_ROCE_figures_show_for_Kwality_Pharmaceuticals_Ltd\"><\/span><strong>What do the ROE and ROCE figures show for Kwality Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals Ltd. reported ROE of 28.21% and ROCE of 26.35% in the supplied data. Both are above the same-industry medians of 10.21% and 12.96%, indicating stronger profitability than the benchmark midpoint.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Kwality_Pharmaceuticals_Ltd_in_the_stock_news_today\"><\/span><strong>Why is Kwality Pharmaceuticals Ltd. in the stock news today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals Ltd. is in stock news today because it touched a fresh 52-week high of Rs 3,444.60 and rose 8.44% in the session. The supplied data confirms the price event but not a company-specific catalyst.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kwality Pharmaceuticals Ltd. Share Price hits a new 52-week high at Rs 3,395.2. marking a 8.44% rise today. Market cap stands at Rs 2,707.2 crore.<\/p>\n","protected":false},"author":29,"featured_media":195105,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-195106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["195105"],"rank_math_title":["Kwality Pharmaceuticals Ltd. Share Price at 52-Week High"],"rank_math_description":["Kwality Pharmaceuticals Ltd. Share Price hit a fresh 52-week high. Check price action, valuation, profitability, sector comparison and peer analysis."],"rank_math_focus_keyword":["Kwality Pharmaceuticals Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Kwality_Pharmaceuticals_Ltd_KPL_Share_Price_Hits_Fresh_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=195106"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195106\/revisions"}],"predecessor-version":[{"id":195107,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195106\/revisions\/195107"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/195105"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=195106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=195106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=195106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}